Search clinical trials for: Oral azacitidine

Total 9010 results

Ajou University School of Medicine

Active, not recruiting

Association of Obesity and Cardiovascular Outcomes in Atrial Fibrillation (Paradox)

Obesity | Atrial Fibrillation | Prognosis | Anticoagulants

Korea, Republic of
Universidade de Passo Fundo

Completed

Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19

Microbial Colonization | Severe COVID-19 | COVID-19 Lower Respiratory Infection | Secondary Bacterial Pneumonia

Brazil
Pfizer

Completed

A Study in Healthy Adult Male Participants to Assess Absorption, Distribution, Metabolism and Excretion (ADME) of Radiolabeled PF-06865571.

Healthy Participants

United States
Medicines for Malaria Venture
Richmond Pharmacology Limited

Completed

A FIH Study to Investigate the Safety, Tolerability and PK of P218

Malaria

United Kingdom
IRCCS Burlo Garofolo

Completed

Early Oral Immunotherapy in Infants With Cow's Milk Protein Allergy

Hypersensitivity, Milk

Italy
University of Sao Paulo

Completed

Analysis of the Clinical and Histological Correlation of Oral Graft-Versus-Host-Disease (GVHD) (ORALGVHD)

Graft-Versus-Host Disease
Georgetown University

Unknown

Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease (PD Nilotinib)

Parkinson Disease | Parkinsons Disease With Dementia

United States
Technische Universität Dresden
AbbVie; University Hospital Heidelberg

Not yet recruiting

Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML (VINCENT)

Acute Myeloid Leukemia

Germany
Institut de Recherches Internationales Servier
Servier Bio-Innovation LLC

Not yet recruiting

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation (PyramIDH)

Myelodysplastic Syndromes (MDS) | Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS)
National Taiwan University Hospital

Not yet recruiting

Demethylating Agent Azacitidine on Prevention of Acute Kidney Injury-chronic Kidney Disease Continuum

Acute Kidney Disease

Taiwan
University of Colorado, Denver
AbbVie

Recruiting

Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
Aprea Therapeutics

Completed

APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell Transplant

Acute Myeloid Leukemia or Myelodysplastic Syndromes

United States
Helsinn Healthcare SA

Terminated

A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States
Celgene

Completed

A Study of Safety, Efficacy and Pharmacodynamics of Azacitidine in Children and Young Adults With Acute Myeloid Leukemia.

Leukemia, Myeloid, Acute

Germany, Netherlands, Denmark
Celgene

Completed

Post Marketing Surveillance to Collect and Evaluate the Safety and Efficacy Information of Korean MDS Patients Treated With VIDAZA®, After Approval of Marketing Authorization for New Drug in Korea

Myelodysplastic Syndrome

Korea, Republic of
S*BIO

Completed

A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine

Myelodysplastic Syndrome | Solid Tumors | Hematologic Malignancies

United States, Singapore
Boston Medical Center
University of Alabama at Birmingham

Withdrawn

Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia

Low-grade Oral Dysplasia

United States
Texas A&M University

Completed

OA Therapy for Mouth-breathers Who Snore (OATMB)

Snoring | Obstructive Sleep Apnea | Mouth Breathing

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Merck Sharp & Dohme LLC

Completed

Study of Azacitidine in Combination With Pembrolizumab in R/R AML Patients and in Newly Diagnosed Older Patients

Acute Myeloid Leukemia

United States
Spero Therapeutics
Simbec Research

Completed

A Study of the Safety, Tolerability, and Pharmacokinetics of SPR720 in Healthy Volunteers

Healthy Volunteers

United Kingdom
Groupe Francophone des Myelodysplasies
Novartis

Unknown

A Study of Combined Deferasirox, Vitamin D and Azacytidine in High Risk MDS (GFM-EXVD-AZA)

MDS

France, Belgium
Pfizer

Completed

Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML

Acute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome

Spain, Canada, Austria, Czechia, France, Hungary, Italy, Japan, Mexico, Poland, United Kingdom
OncoVerity, Inc.
Janssen Research & Development, LLC; argenx

Active, not recruiting

A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy (CULMINATE)

Leukemia, Myeloid, Acute

Switzerland, Israel, Spain, France, Turkey, Italy, Australia, Brazil, Russian Federation
Helsinn Healthcare SA

Completed

Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

United States
The University of Texas Health Science Center,...
M.D. Anderson Cancer Center

Terminated

CytID Analysis of Oral Lesions

Oropharyngeal Cancer | Oral Cavity Cancer

United States
Pfizer

Completed

A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction

Dental Pain

United States
Hôpital Armand Trousseau

Completed

Suspicion of Non IgE-mediated Cow's Milk Protein Allergy: Prevalence and Evolution

Reflux, Gastroesophageal | Atopic Dermatitis | Tolerance | Proctocolitis | Food Allergy in Infants

France
Abbott Nutrition

Completed

Oral Nutritional Supplementation in Picky Eating Children

Children - Malnutrition

India
Janssen Research & Development, LLC

Completed

A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations

Healthy

Belgium
Milton S. Hershey Medical Center

Completed

Oral Liposomal Glutathione Supplementation in Healthy Subjects

Healthy

United States
Galapagos NV

Completed

Oral Bioavailability of Solid Formulation of GLPG1837 With and Without Food

Healthy

Belgium
Pfizer

Completed

A Study to Understand How the Study Medicine (PF-07081532) is Processed and Eliminated in Healthy Men

Healthy Participants

Netherlands
Jordan University of Science and Technology

Completed

Effect of Oral Health Education on Oral Health Status, Treatment Needs and Barriers to Care

Gingivitis | Dental Caries

Jordan
Medicines for Malaria Venture
Cross Research S.A.

Completed

Safety Tolerability & Pharmacokinetics of Co-administered Single Doses of OZ439 & Piperaquine to Healthy Subjects

Healthy

Switzerland
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Physiological Effects of ANGPTL3 Variants in Humans

Hypocholesterolemia

United States
Stephen E. Feinberg

Terminated

Phase II Clinical Trial of Intraoral Grafting of Human Tissue Engineered Oral Mucosa

Disorder of Oral Mucous Membrane

United States
Université de Sherbrooke
Canadian Diabetes Association

Completed

Early Screening for Gestational Diabetes Mellitus (DG2)

Gestational Diabetes Mellitus

Canada
National Taiwan University Hospital

Completed

To Study the Effect of β-glucans on Wound Healing

Burns

Taiwan
GlaxoSmithKline

Completed

A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects.

HIV Infection | Infection, Human Immunodeficiency Virus

United States
Prelude Therapeutics

Terminated

PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies

Follicular Lymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Myeloproliferative Neoplasm | Small Lymphocytic Lymphoma | B-cell Non-Hodgkin Lymphoma

United States
Takeda

No longer available

Expanded Access Program With Pevonedistat (Given With Azacitidine) for Adults With Higher-risk Myelodysplastic Syndromes

Myelodysplastic Syndromes
Technische Universität Dresden

Completed

Treatment of Patients With Myelodysplastic Syndrome or Acute Myelocytic Leukemia With an Impending Hematological Relapse With Azacitidine (Vidaza) (RELAZA2)

Myelodysplastic Syndrome | Acute Myelocytic Leukemia

Germany
Fujifilm Pharmaceuticals U.S.A., Inc.

Withdrawn

A Study of FF-10501-01 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)
Celgene

Completed

Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes

Taiwan
Hutchison Medipharma Limited

Terminated

Phase I Study of HMPL-523+Azacitidine in Elderly Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
TetraLogic Pharmaceuticals

Terminated

Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL

Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS)

United States, Spain, Australia, Germany
Foresee Pharmaceuticals Co., Ltd.

Completed

Multiple-Dose, Dose-Escalation Study to Evaluate the Safety/Tolerability and Pharmacokinetics of FP-045

Healthy Volunteers

Australia
Guzide UGUCU

Completed

Effects of the Different Concentrations of Oral Dextrose Solution Applying With Supportive Positions on Pain During Heel-Stick Sampling in Premature Infants

Pain

Turkey
University of Leipzig

Completed

Necessity of Transnasal Gastroscopy in Routine Diagnostics - a Patient Centered Requirement Analysis

Patient Safety

Germany
University of Wisconsin, Madison
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients

Clostridium Difficile Infection Recurrence

United States

Search clinical trials for: Oral azacitidine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations